Who is sponsoring NCT03499366?

NCT03499366 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT03499366?

Interventions in NCT03499366: HFMS, MRC, ACTIVLIM, PedsQl-4.0.

What condition does NCT03499366 study?

NCT03499366 studies Flaccid Hemiplegia, Flaccid Paraplegia, Flaccid Tetraplegia, Unspecified, Enterovirus D68, Myelitis, Infectious.

Is NCT03499366 still recruiting?

NCT03499366 is currently status unknown. Last updated 11 May 2018.

Last reviewed 2018-05-11 · How we verify

NCT03499366

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

European Paediatric AFM Associated With EV-D68 Follow-up Study.

Status unknown NA Last updated 11 May 2018

What this trial tests

NA trial testing HFMS, MRC, ACTIVLIM, PedsQl-4.0 in Flaccid Hemiplegia in 40 participants. Status unknown.

Timeline

9 April 2018

Primary endpoint
9 April 2020

1 May 2020

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	9 April 2018
Primary completion	9 April 2020
Estimated completion	1 May 2020
Sites	1 location across Norway

Drugs / interventions tested

HFMS, MRC, ACTIVLIM, PedsQl-4.0

Conditions studied

Flaccid Hemiplegia — all drugs for Flaccid Hemiplegia →
Flaccid Paraplegia — all drugs for Flaccid Paraplegia →
Flaccid Tetraplegia, Unspecified — all drugs for Flaccid Tetraplegia, Unspecified →
Enterovirus D68 — all drugs for Enterovirus D68 →

Sponsor

Oslo University Hospital

Who can join

Adults 1 Day to 18, any sex, with Flaccid Hemiplegia or Flaccid Paraplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a follow-up study on children with acute flaccid paresis associated with enterovirus D68 infection. Only children living in Europe are eligible. The study aim is to clarify the outcome of the disease and investigate possible clinical correlation with outcome, including initial severity, demographic characteristics, treatment and MRI findings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03499366 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 11 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03499366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing